Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Panel: Return to Cancer Screenings Post COVID Breast Cancer Philip Lammers, MD, MSCI Baptist Cancer Center Memphis, TN Disclosure of Conflicts of Interest Philip Lammers, MD, MSCI, has the following financial relationships to disclose: Consultant - AstraZeneca, Daiichi Sankyo, Pfizer, Puma, Sanofi, and Tempusi COVID-19 Impact on Breast Cancer Screening …
Rockville, MD - A new CANCER BUZZ podcast episode reveals the benefits of liquid biopsies for both cancer care teams and patients, including advancing health equity, early diagnosis, and enhanced biologic understanding of tumor mutations. In the latest episode, podcast guest Stephen Quake, PhD, Professor of Bioengineering and Applied Physics at Stanford University and Co-President of the Chan …
Panel: Return to Cancer Screenings Post Covid Colon Cancer Reid M. Ness, MD, MPH Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center Disclosure of Conflicts of Interest Reid M. Ness, MD, MPH has the following financial relationships to disclose: Speaker - Guardant Health, Inc. Updates in Screening Recommendations for Colorectal Cancer …
1 | Lung Cancer Screening and Nodule Management Program CONFIDENTIAL – Contains proprietary information. Not intended for external distribution. Return to Cancer Screenings Post COVID Lung Cancer Susan Garwood, M. D. HCA Physician Lead Pulmonary Services Disclosure of Conflicts of Interest Consultant and speaker – Auris Health and Biodesix Susan Garwood, MD, has the …
Accelerated Approvals Reconsidered On April 21, the FDA convened its Oncology Drug Advisory Committee (ODAC) to discuss the use of PI3K inhibitors for treating hematologic malignancies. The class of drugs under discussion target the phosphoinositide 3-kinase (PI3K) pathway, whose dysregulation has been implicated in assorted oncologic and autoimmune diseases. The meeting was occasioned by “concerning …
Ahead of this year's Prescription Drug User Fee Act (PDUFA) reauthorization, ACCC and 88 other patient and provider advocacy organizations urged congressional leadership to pass legislation that would improve the diversity of enrollment in clinical trials. The letter expresses support for a number of policy proposals, including provisions from the DIVERSE Trials Act (H.R. 5030/S. 2706) and the DEPICT …
The White House Briefing Room The White House announces private sector commitments in response to the call to action from President Biden and First Lady Jill Biden on cancer screening. These new actions and collaborations mark progress toward the Cancer Moonshot goal to decrease the death rate from cancer by at least 50 percent over the next 25 years. Just under 100 days ago, President Biden reignited …
May 11, 2022
Industry experts share strategies for maximizing labor and patient volume during staffing shortages while simultaneously reducing labor costs. This session provides cancer programs and practices with a practical framework built around the hard truths facing today’s workforce. Speakers: Matt Dane, DNP, MBA, RN Vice President of Einstein II, Hallmark Health Care Solutions Jennifer Firmalan VP of Workforce …
The final post in a three-blog series, ACCCBuzz spoke to Megan Morava, PA-C, and Alexandra Greenawalt who share how one independent oncology practice and local community center are taking action to improve equitable cancer care delivery at the local level.
Founded in 1988, the Texas Society of Clinical Oncology (TxSCO) is a powerful community of multidisciplinary care providers involved in the treatment of patients with cancer. TxSCO is a state Chapter Member of the Association of Community Cancer Centers (ACCC) and a State Affiliate of the American Society of Clinical Oncology. Members receive valuable educational content and innovative …
Abstract - MSCO Spring Conference 2022 RESEARCH POSTER PRESENTATION DESIGN © 2015 www .PosterP resen tations .com • Non-small cell lung cancer(NSCLC) has propensity to metastasize to bones – around 40%. • Bone Marrow involvement very rare, unlike in SCLC • Persistent cytopenias as a result of diffuse bone marrow infiltration is uncommon • Bone Marrow biopsy is not …
Combined effects of AAV-TrkB and BDNF-MSC Treatment on Diaphragm Muscle Recovery Across Motor Behaviors after Cervical Spinal Cord Injury Preethiya Sekar, Ran Zhao, Sarah Bennis, Shalini Kulasingam Background Findings Methods • Cervical cancer is the fourth most common cancer in women worldwide • In 2020, more than half a million new cases were detected, and more than …
PowerPoint Presentation ACC1 Inhibition Enhances Regulatory T-cell Suppressive Function by Controlling the Choice Between Fatty-Acid Synthesis and Oxidation Cameron McDonald-Hyman1,2, Ethan G Aguilar2,3, Keli L Hippen2,3, Bruce R Blazar2,3 Author Affiliations: 1. Division of Hematology/Oncology/Transplantation, Department of Medicine, University of Minnesota, Minneapolis MN 2. The Center …
PowerPoint Presentation Rituximab Induced Early Phase Neutropenia in IgG4-Related Disease Ashley Draisey, DO, Austin Cudak, DO, Julie Jones, DO; Abbott Northwestern Hospital, Minneapolis, MN CASE PRESENTATION • A middle-aged female with biopsy-confirmed IgG4- related disease receiving rituximab presented to the emergency department with worsening chronic neck pain and swelling …
Saranya Prathibha, MD, University of Minnesota, Minnesota MN View Poster
Preethiya Sekar, et al., University of Minnesota, Minnesota MN View Poster
Nidhi Desai, MD, et al., University of Minnesota, Minnesota MN View Poster
Hyperviscosity Related to Waldenström Macroglobulinemia Treated with Plasmapheresis REFERENCES 1) Nambirajan A, Singh V, Bhardwaj N, Mittal S, Kumar S, Jain D. SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature. Arch Pathol Lab Med. 2021 Jan 1;145(1):90-98. doi: 10.5858/arpa.2019-0633-OA. PMID: 33367658. 2) Paz-Ares L, Ciuleanu TE, Cobo …
McKenzie J White, MD, et al., University of Minnesota, Minnesota MN View Poster